This transaction
This share acquisitionThe voting-rights ratio is the share of the votes exercisable at a shareholders’ meeting that will be held after this transaction.The percentage before the change is not stated in this document.
Proposal, implementation, maintenance and support of receipt computers, electronic medical records and peripheral equipment for clinics and small hospitals as a Japan Medical IT Support provider; medical information systems; development and sales of proprietary products; and consulting services
The specific impact of the consolidation on results for the fiscal year ending March 2027 is currently under review. The company will promptly disclose any material matters requiring disclosure once identified.
| Item | Details |
|---|---|
| Transaction name | This share acquisition |
| Counterparty name | ラジエンスウエア株式会社 |
| Name of the Subject Company | ラジエンスウエア株式会社 |
| Business Description of the Subject Company | Proposal, implementation, maintenance and support of receipt computers, electronic medical records and peripheral equipment for clinics and small hospitals as a Japan Medical IT Support provider; medical information systems; development and sales of proprietary products; and consulting services |
| Location of the Subject Company | Kam isato Town, Kodama County, Saitama Prefecture |
| Capital Stock of the Subject Company | ¥83.75 million |
| Date of Establishment of the Subject Company | January 2000 |
| Number of shares acquired | Acquisition of 100% of the common shares. The number of shares and voting rights is Not disclosed |
| Voting rights ownership percentage | After 100％ (before not disclosed) |
| Impact on Business Performance | The specific impact of the consolidation on results for the fiscal year ending March 2027 is currently under review. The company will promptly disclose any material matters requiring disclosure once identified. |
| Date of board resolution | 19 March 2026 |
| Execution Date / Effective Date | 1 April 2026 |
| Management structure after acquisition | Effective 1 April 2026, Nakajima Yoshio (中嶋 吉男) changed from representative director to adviser. On the same date, Aoki Masayuki (青木 正之) became representative director and president. ラジエンスウエア株式会社 became a consolidated subsidiary of the company. |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company aims to maximize earnings in its medical business by incorporating ラジエンスウエア株式会社's customer base and sales network in the Tokyo metropolitan area and northern Kanto, thereby accelerating the transition to a direct-sales model for the Group. It also aims to expand maintenance and service offerings for approximately 475 existing customers, promote the introduction of Group products, improve efficiency through sales-channel integration, and expand recurring revenue.